Protagonist Therapeutics Inc (NASDAQ: PTGX) Hogging The Spotlight Today
Currently, there are 57.71M common shares owned by the public and among those 55.64M shares have been available to trade. The company’s stock has a 5-day price change of 2.90% and 52.36% over the past three months. PTGX shares are trading 87.05% year to date (YTD), with the 12-month market performance up to 115.20% higher. […]
Uncovering Institutional Buying In Protagonist Therapeutics Inc (NASDAQ: PTGX)
Currently, there are 57.71M common shares owned by the public and among those 55.40M shares have been available to trade. The company’s stock has a 5-day price change of 9.08% and 23.58% over the past three months. PTGX shares are trading 50.85% year to date (YTD), with the 12-month market performance up to 25.24% higher. […]
Growth Story Still Intact For Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX) concluded trading on Thursday at a closing price of $28.52, with 4.61 million shares of worth about $131.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 53.58% during that period and on Thursday, February 01 price saw a gain […]
